Suchergebnisse - "Pan, Jingxuan"

PubPharm (12)

1

Preclinical development of a novel BCR-ABL T315I inhibitor against chronic myeloid leukemia

enthalten in: Cancer letters | 2020

von Gupta, P. | Zhang, G. | Barbuti, A. | +8

2

Class III-specific HDAC inhibitor Tenovin-6 induces apoptosis, suppresses migration and eliminates cancer stem cells in uveal melanoma

enthalten in: Scientific reports | 2016

von Dai, W. | Zhou, J. | Jin, B. | +1

3

Tenovin-6-mediated inhibition of SIRT1/2 induces apoptosis in acute lymphoblastic leukemia (ALL) cells and eliminates ALL stem/progenitor cells

enthalten in: BMC cancer | 2015

von Jin, Y. | Cao, Q. | Chen, C. | +3

4

Antitumor activity of S116836, a novel tyrosine kinase inhibitor, against imatinib-resistant FIP1L1-PDGFRα-expressing cells

enthalten in: Oncotarget | 2014

von Shen, Y. | Ren, X. | Ding, K. | +3

5

SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells

enthalten in: Cancer biology & therapy | 2014

von Bu, Q. | Cui, L. | Li, J. | +4

6

Identification of GZD824 as an orally bioavailable inhibitor that targets phosphorylated and nonphosphorylated breakpoint cluster region-Abelson (Bcr-Abl) kinase and overcomes clinically acquired mutation-induced resistance against imatinib

enthalten in: Journal of medicinal chemistry | 2013

von Ren, X. | Pan, X. | Zhang, Z. | +17

7

The conformational control inhibitor of tyrosine kinases DCC-2036 is effective for imatinib-resistant cells expressing T674I FIP1L1-PDGFRα

enthalten in: PloS one | 2013

von Shen, Y. | Shi, X. | Pan, J.

8

Pristimerin induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation by blocking NF-kappaB signaling and depleting Bcr-Abl

enthalten in: Molecular cancer | 2010

von Lu, Z. | Jin, Y. | Chen, C. | +3

ErratumIn: Mol Cancer. 2021 Dec 31;20(1):172. - PMID 34969396

9

Celastrol, a novel HSP90 inhibitor, depletes Bcr-Abl and induces apoptosis in imatinib-resistant chronic myelogenous leukemia cells harboring T315I mutation

enthalten in: Cancer letters | 2010

von Lu, Z. | Jin, Y. | Qiu, L. | +2

10

Design, synthesis, and biological evaluation of novel water-soluble triptolide derivatives : Antineoplastic activity against imatinib-resistant CML cells bearing T315I mutant Bcr-Abl

enthalten in: Bioorganic & medicinal chemistry | 2010

von Xu, F. | Shi, X. | Li, S. | +6